98%
921
2 minutes
20
The compound FR901379, a sulfated echinocandin produced by the filamentous fungus F-11899, is an important intermediate for the synthesis of the antifungal drug micafungin. In this study, we established an efficient clustered regularly interspaced short palindromic repeats/Cas9-based gene editing tool for the industrial production strain SIPI1284. With this method, the efficiency of gene mutagenesis in the target locus is up to 84%, which enables the rapid gene disruption for the analysis of FR901379 biosynthetic genes. Next, we verified the putative functional genes of the FR901379 biosynthetic gene cluster via gene disruption and gene complementation in vivo. These core functional genes included the nonribosomal peptide synthetase gene (), the fatty-acyl-AMP ligase gene () responsible for the formation of the activated form of palmitic acid and its transfer to , four nonheme mononuclear iron oxygenase genes (, , , and ) responsible for the synthesis of nonproteinogenic amino acids, l-homotyrosine biosynthesis genes (), two cytochrome P450 enzyme genes ( and ), and a transcription regulator gene (). In addition, by screening the whole genome, we identified two unknown genes ( and ) responsible for the sulfonyloxy group of FR901379, which were separated from the core FR901379 biosynthetic cluster. Furthermore, during gene disruptions in the research, we obtained a series of FR901379 analogues and elucidated the relationship between the groups and antifungal activities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acschembio.2c00250 | DOI Listing |
Mar Drugs
May 2024
Ocean College, Zhejiang University, Zhoushan 316021, China.
Microb Biotechnol
January 2024
Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu, Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Metab Eng
November 2022
Shandong Provincial Key Laboratory of Synthetic Biology, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101, China; Key Laboratory of Biofuels, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101,
Micafungin, a semisynthetic derivative of the cyclic hexapeptide FR901379 produced by Coleophoma empetri fermentation, is the only O-sulfonated echinocandin-type antifungal drug. However, the detailed formation mechanism of O-sulfonate group, whether before or after the assembly of hexapeptide, remains elusive. Here, we confirmed that O-sulfonylation occurs after hexapeptide assembly as a kind of postmodification in the biosynthesis of FR901379.
View Article and Find Full Text PDFACS Chem Biol
August 2022
State Key Laboratory of New Drug and Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai Institute of Pharmaceutical Industry, Shanghai 201203, China.
Front Microbiol
August 2021
Shandong Provincial Key Laboratory of Synthetic Biology, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China.
Micafungin is an important echinocandin antifungal agent for the treatment of invasive fungal infections. In industry, micafungin is derived from the natural product FR901379, which is a non-ribosomal cyclic hexapeptide produced by the filamentous fungus . The difficulty of genetic manipulation in restricts the clarification of FR901379 biosynthetic mechanism.
View Article and Find Full Text PDF